Device Trial Radar · NCT06203054
CLIP-IT Post-Market Study
Last checked: Nov 20, 2026Latest source record: Oct 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
198
Actual
Start
Feb 26, 2024
Primary completion
Aug 26, 2025
Study completion Feb 2029
Sponsor
- Lead sponsor
- Medtronic Cardiac SurgeryPublic (MDT)
- Sponsor type
- Industry
- First posted
- Jan 12, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to collect post-market clinical evidence on performance and clinical outcomes of the Penditure™ Left Atrial Appendage (LAA) Exclusion System in subjects undergoing concomitant cardiac surgery.
Conditions
- Left Atrial Appendage Exclusion
Interventions
Penditure™ Left Atrial Appendage (LAA) Exclusion SystemDevice
Exclusion of the left atrial appendage using the Penditure™ Left Atrial Appendage (LAA) Exclusion System in subjects undergoing concomitant cardiac surgery.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Rate of Successful Exclusion of the Left Atrial Appendage (LAA) From the HeartTime frame: 3 months post procedure
- Rate of Device-related Serious Adverse Cardiac EventsTime frame: 30 days post procedure
Locations
15 sites in 1 country. Site status is shown where the registry gives one.
Emory Saint Joseph's Hospital
Atlanta, Georgia
Northwestern Memorial Hospital
Chicago, Illinois
Ascension St. Vincent Heart Center
Carmel, Indiana
12 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.